Torrent Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Torrent Pharmaceuticals Limited has submitted its financial results to the NSE for the period ended March 31, 2026. This appears to be the Q4 FY2026 results filing. The company is a major Indian pharmaceutical player engaged in the manufacturing and marketing of generic drugs. As a standard regulatory filing, the exchange has received the audited/unaudited financial statements including revenue, profit after tax (PAT), and other key metrics for the quarter and full year.
The filing is routine and expected for a listed company. Actual stock impact will depend on whether results beat, meet, or miss market expectations. Shareholders should review the detailed P&L and balance sheet figures once released.